Pegylated interferon-alfa-2A plus adefovir combination therapy is superior to pegylated interferon-alfa-2A alone or adefovir monotherapy in reducing HBsAg levels in hdvcoinfected patients with low HBV viremia

Basit Öğe Kaydı
dc.contributor.authorWedemeyer, Heiner
dc.contributor.authorYurdaydin, Cihan
dc.contributor.authorZachou, Kalliopi
dc.contributor.authorErhardt, Alexander
dc.contributor.authorDrebber, Ulrike
dc.contributor.authorCakaloglu, Ya
dc.contributor.authorDegertekin, Ha
dc.date.accessioned2024-04-24T17:49:54Z
dc.date.available2024-04-24T17:49:54Z
dc.date.issued2006
dc.departmentDicle Üniversitesien_US
dc.description57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- OCT 27-31, 2006 -- Boston, MAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.endpage554Aen_US
dc.identifier.issn0270-9139
dc.identifier.issue4en_US
dc.identifier.startpage553Aen_US
dc.identifier.urihttps://hdl.handle.net/11468/23080
dc.identifier.volume44en_US
dc.identifier.wosWOS:000241362302075
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherJohn Wiley & Sons Incen_US
dc.relation.ispartofHepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titlePegylated interferon-alfa-2A plus adefovir combination therapy is superior to pegylated interferon-alfa-2A alone or adefovir monotherapy in reducing HBsAg levels in hdvcoinfected patients with low HBV viremiaen_US
dc.titlePegylated interferon-alfa-2A plus adefovir combination therapy is superior to pegylated interferon-alfa-2A alone or adefovir monotherapy in reducing HBsAg levels in hdvcoinfected patients with low HBV viremia
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu